Test Procedure for §170.304.a Computerized Provider Order Entry APPROVED Version 1.1 September 24, 2010 Test Procedure for §170.304 (a) Computerized Provider Order Entry
This document describes the test procedure for evaluating conformance of complete EHRs or EHR
modules1 to the certification criteria defined in 45 CFR Part 170 Subpart C of the Final Rule for Health
Information Technology: Initial Set of standards, Implementation Specifications, and Certification Criteria
for Electronic Health Record Technology as published in the Federal Register on July 28, 2010. The
document2 is organized by test procedure and derived test requirements with traceability to the normative
certification criteria as described in the Overview document located at
http://healthcare.nist.gov/docs/TestProcedureOverview_v1.pdf. The test procedures may be updated to
reflect on-going feedback received during the certification activities.
The HHS/Office of the National Coordinator for Health Information Technology (ONC) has defined the
standards, implementation guides and certification criteria used in this test procedure. Applicability and
interpretation of the standards, implementation guides and certification criteria to EHR technology is
determined by ONC. Test procedures to evaluate conformance of EHR technology to ONC’s
requirements are defined by NIST. Testing of EHR technology is carried out by ONC-Authorized Testing
and Certification Bodies (ATCBs), not NIST, as set forth in the final rule establishing the Temporary
Certification Program (Establishment of the Temporary Certification Program for Health Information Technology, 45 CFR Part 170; June 24, 2010.)
Questions about the applicability of the standards, implementation guides or criteria should be directed to
ONC at ONC.Certification@hhs.gov. Questions about the test procedures should be directed to NIST at
hit-tst-fdbk@nist.gov. Note that NIST will automatically forward to ONC any questions regarding the
applicability of the standards, implementation guides or criteria. Questions about functions and activities
of the ATCBs should be directed to ONC at ONC.Certification@hhs.gov .
CERTIFICATION CRITERIA
This Certification Criterion is from the Health Information Technology: Initial Set of Standards,
Implementation Specifications, and Certification Criteria for Electronic Health Record Technology Final
Rule issued by the Department of Health and Human Services (HHS) on July 28, 2010.
§170.304 (a) Computerized provider order entry. Enable a user to electronically record, store, retrieve,
and modify, at a minimum, the following order types:
1 Department of Health and Human Services, 45 CFR Part 170 Health Information Technology: Initial Set of Standards, Implementation Specifications, and Certification Criteria for Electronic Health Record Technology, Final Rule, July 28, 2010. 2 Disclaimer: Certain commercial products are identified in this document. Such identification does not imply recommendation or endorsement by the National Institute of Standards and Technology.
Test Procedure for §170.304.a Computerized Provider Order Entry APPROVED Version 1.1 September 24, 2010
Per Section III.D of the preamble of the Health Information Technology: Initial Set of Standards,
Implementation Specifications, and Certification Criteria for Electronic Health Record Technology, Final
Rule where the computerized provider order entry certification criterion is discussed:
“We clarify that the adopted certification criteria related to CPOE pertain only to the ordering, and
not to the delivery of results (reports or images).”
INFORMATIVE TEST DESCRIPTION
This section provides an informative description of how the test procedure is organized and conducted. It
is not intended to provide normative statements of the certification requirements.
This test evaluates the capability for a complete EHR or EHR Module to enable a user to electronically
record, store, modify and retrieve the following order types in an ambulatory setting:
The test procedure is not prescriptive about the method used to modify the problem list. For example,
modifying an order does not require modifying an existing instance of an order. Modification may be
accomplished through discontinuing/canceling an existing order and entering a new order.
This test procedure is organized into three sections:
Record and Store - evaluates the capability to electronically enter and store orders for medications,
laboratory, and radiology/imaging within the EHR system in an ambulatory setting
The Tester enters the NIST-supplied Test Data orders for medications, laboratory, and
The Tester verifies that the orders are stored in the EHR
Modify - evaluates the capability for a user to electronically modify entered orders for medications,
laboratory, and radiology/imaging in the EHR in an ambulatory setting
The Tester displays the entered orders for medications, laboratory, and radiology/imaging
Tester modifies the medications, laboratory, and radiology/imaging orders
The Tester validates that the modified orders are accurate and complete
Retrieve - evaluates the capability to retrieve and display the orders that have been previously
entered into the EHR in an ambulatory setting
The Tester displays the orders for medications, laboratory, and radiology/ imaging entered
The Tester validates that the displayed order data are accurate and complete
Test Procedure for §170.304.a Computerized Provider Order Entry APPROVED Version 1.1 September 24, 2010 REFERENCED STANDARDS
None NORMATIVE TEST PROCEDURES Derived Test Requirements
Electronically Record and Store Orders in an Ambulatory Setting
Electronically Modify Orders in an Ambulatory Setting
Electronically Retrieve Orders in an Ambulatory Setting
DTR170.304.a – 1: Electronically Record and Store Orders in an Ambulatory Setting
Vendor shall identify a patient with an existing record in the EHR to be used for
Vendor shall identify the EHR function(s) that are available to: 1) select the
patient, 2) enter and store orders for medications, laboratory, and
radiology/imaging, 3) modify orders for medications, laboratory, and
radiology/imaging, and 4) retrieve orders for medications, laboratory, and
radiology/imaging in an ambulatory setting
Tester shall select order test data from one NIST-supplied test data set in
Using the EHR function(s) identified by the Vendor, the Tester shall select the
patient’s existing record and enter orders from the selected test data set in
TD170.304.a–1 for medications, laboratory, and radiology/imaging
Using the NIST-supplied Inspection Test Guide, the Tester shall verify that the
orders have been entered correctly and without omission
Inspection Test Guide IN170.304.a – 1.01:
Using the data in the selected NIST-supplied test data set in TD170.304.a – 1,
Tester shall verify that the order test data are entered correctly and without
Tester shall verify that the order data are stored in the patient’s record for:
medications laboratory radiology/imaging
Test Procedure for §170.304.a Computerized Provider Order Entry APPROVED Version 1.1 September 24, 2010 DTR170.304.a – 2: Electronically Modify Orders in an Ambulatory Setting
As defined in DTR170.304.a – 1, no additional information is required
Tester shall select order test data from one NIST-supplied test data set in
TD170.304.a – 2 that corresponds to the data set selected for DTR170.304.a – 1:
Electronically Record and Store Orders in an Ambulatory Setting
Using the EHR function(s) identified by the Vendor, the Tester shall select the
patient’s existing record, shall display the order data entered during the
DTR170.304.a – 1: Electronically Record and Store Orders test, and shall modify
the previously entered orders for medications, laboratory, and radiology/ imaging
Using the NIST-supplied Inspection Test Guide, the Tester shall verify that the
orders that were entered in TE170.304.a – 2.02 have been entered correctly and
Using the data in the selected NIST-supplied test data set in TD170.304.a – 2,
Tester shall verify that the medication, laboratory, and radiology/imaging order
data entered and stored during the DTR170.304.a – 1: Electronically Record and
Store Orders test are accessed and modified correctly and without omission
Tester shall verify that the modified orders are stored in the patient record
medications laboratory radiology/imaging
DTR170.304.a – 3: Electronically Retrieve Orders in an Ambulatory Setting
As defined in DTR170.304.a – 1, no additional information is required
Using the EHR function(s) identified by the Vendor, the Tester shall select the
patient’s existing record and display the orders the Tester entered during the
DTR170.304.a – 1: Electronically Record and Store Orders and DTR170.304.a –
2: Electronically Modify Orders tests for medications, laboratory, and
Test Procedure for §170.304.a Computerized Provider Order Entry APPROVED Version 1.1 September 24, 2010 TE170.304.a – 3.02:
Using the NIST-supplied Inspection Test Guide, the Tester shall verify that the
order data display correctly and without omission
Using the data in the NIST-supplied test data set in TD170.304.a – 3 that
corresponds to the data set selected for DTR170.304.a – 1: Electronically
Record and Store Orders in an Ambulatory Setting, Tester shall verify that the
order data entered during the DTR170.304.a – 1: Electronically Record and
Store Orders and DTR170.304.a – 2: Electronically Modify Orders tests display
correctly and without omission, including
medications laboratory radiology/imaging
TEST DATA
Test data is provided by NIST in this Test Procedure to ensure that the functional and interoperable
requirements identified in the criteria can be adequately evaluated for conformance, as well as to provide
consistency in the testing process across multiple ONC-Authorized Testing and Certification Bodies
(ATCBs). The NIST-supplied test data focus on evaluating the basic capabilities required of EHR
technology, rather than exercising the full breadth/depth of capability that installed EHR technology might
be expected to support. The test data is formatted for readability of use within the testing process. The
format is not prescribing a particular end-user view or rendering. No additional requirements should be
The Tester shall use and apply the NIST-supplied test data during the test, without exception, unless one
The Tester determines that the Vendor product is sufficiently specialized that the NIST-supplied
test data needs to be modified in order to conduct an adequate test. Having made the
determination that some modification to the NIST-supplied test data is necessary, the Tester shall
record the modifications made as part of the test documentation.
The Tester determines that changes to the test data will improve the efficiency of the testing
process; primarily through using consistent demographic data throughout the testing workflow.
The Tester shall ensure that the functional and interoperable requirements identified in the
criterion can be adequately evaluated for conformance and that the test data provides a
Any departure from the NIST-supplied test data shall strictly focus on meeting the basic capabilities
required of EHR technology relative to the certification criterion rather than exercising the full
breadth/depth of capability that installed EHR technology might be expected to support.
Test Procedure for §170.304.a Computerized Provider Order Entry APPROVED Version 1.1 September 24, 2010
The Test Procedures require that the Tester enter the test data into the EHR technology being evaluated
for conformance. The intent is that the Tester fully controls the process of entering the test data in order
to ensure that the data are correctly entered as specified in the test procedure. If a situation arises where
it is impractical for a Tester to directly enter the test data, the Tester, at the Tester’s discretion, may
instruct the Vendor to enter the test data, so long as the Tester remains in full control of the testing
process, directly observes the test data being entered by the Vendor, and validates that the test data are
entered correctly as specified in the test procedure.
TD170.304.a – 1: Record and Store Orders in an Ambulatory Setting
TD170.304.a – 1.1: Medication Orders Amoxil 250 mg oral suspension, Disp #150 ml, Sig: Take 5 ml q8h X 10 days, 0 Refills Plavix 75 mg tablet, Disp #30, Sig: Take 1 tablet QD, 1 Refill Catapres 0.1 mg tablet, Disp #60, Sig: Take 1 tablet bid, 1 Refill
TD170.304.a – 1.2: Laboratory Orders Complete Blood Count w/ Differential (CBC), every other day times 3 BUN,
TD170.304.a – 1.3: Radiology/Imaging Orders Chest X-ray 2 views, routine, indication: pneumonia MRI without contrast, neck, routine, indication: neck pain Orders test Data – Set 2
TD170.304.a – 1.4: Medication Orders Glyburide (Diabeta) 2.5 mg tablet, Disp # 60, Sig: Take 1 tablet PO, Q AM, 0 Refills atorvastatin calcium (Lipitor) 10 mg tablet, Disp # 60, Sig: Take 1 tablet PO Qday, 1 Refill candesartan cilexetil (Atacand), 16 mg tablet, Disp# 60, Sig: Take 1 tablet PO QDay, 1 Refill
TD170.304.a – 1.5: Laboratory Orders Cholesterol,
Thyroid Stimulating Hormone (TSH), routine High-sensitivity C-reactive protein (HS-CRP), routine
TD170.304.a – 1.6: Radiology/Imaging Orders X-ray: AP Pelvis, Anteroposterior ( AP) & Lateral/Right Hip, routine, indication: hip pain DXA scan (Bone Density test), routine, indication: osteoporosis
Test Procedure for §170.304.a Computerized Provider Order Entry APPROVED Version 1.1 September 24, 2010 TD170.304.a – 2: Modify Orders in an Ambulatory Setting
Modify the Amoxil order from q8h to q12h Discontinue the Plavix order Modify the dose for the Catapres order from 0.1 mg to 0.2mg Discontinue the Complete Blood Count w/ Differential (CBC) order Modify the Triglycerides order from routine to once a week times 3 weeks
TD170.304.a – 2.3: Radiology/Imaging Orders
Modify the Chest X-ray 2 views order to Chest X-ray 4 views Modify candesartan cilexetil (Atacand) order from 16 mg tablet to 8 mg tablet Modify Cholesterol from routine to fasting
TD170.304.a – 2.6: Radiology/Imaging Orders
Modify X-ray: AP Pelvis, Anteroposterior ( AP) & Lateral/Right Hip to Bilateral Hip TD170.304.a – 3: Retrieve Orders in an Ambulatory Setting
Revised Medication Orders List Amoxil 250 mg oral suspension, Disp #100 ml, Sig: Take 5 ml q12h X 10 days, 0 Refills Catapres 0.2 mg tablet, Disp #60, Sig: Take 1 tablet bid, 1 Refill once a week times 3 weeks
Fasting Blood Glucose in AM
Test Procedure for §170.304.a Computerized Provider Order Entry APPROVED Version 1.1 September 24, 2010
Chest X-ray 4 views, routine, indication: pneumonia MRI without contrast, neck, routine, indication: neck pain
Revised Medication Orders List Glyburide (Diabeta) 2.5 mg tablet, Disp # 60, Sig: Take 1 tablet PO, Q AM atorvastatin calcium (Lipitor) 10 mg tablet, Disp # 60, Sig: Take 1 tablet PO Qday candesartan cilexetil (Atacand), 8 mg tablet, Disp# 60, Sig: Take 1 tablet PO QDay
Revised Laboratory Orders List Cholesterol,
Thyroid Stimulating Hormone (TSH), routine High-sensitivity C-reactive protein (HS-CRP), routine
Revised Radiology/Imaging Orders List X-ray: AP Pelvis, Anteroposterior ( AP) & Lateral/Bilateral,routine, indication: hip pain DXA scan (Bone Density test), routine, indication: osteoporosis
CONFORMANCE TEST TOOLS
Test Procedure for §170.304.a Computerized Provider Order Entry APPROVED Version 1.1 September 24, 2010
Document History Version Number Description Date Published
Updated to remove “Pending” from header
Removed “draft” from introductory paragraph
Added verbiage to clarify the definition of modify
In the Normative Test Procedures Section
Added references to the Test Data section
Added verbiage instructing Tester to select only one
Added verbiage instructing Tester to select a data set
from the Test Data that corresponds to the data set selected for DTR170.304.a – 1: Electronically Record and Store Orders in an Ambulatory Setting
Changed the word “change” to “modify”
Corrected “Disp #150 ml to “Disp #100 ml”
El Port del Garraf renova la Bandera Blava 2010 El director general de Ports, Aeroports i Costes del DPTOP, Oriol Balaguer, va lliurar el 8 de juliol les banderes blaves als ports guardonats, entre els que es troba el Port del Garraf. Aquest any, l'acte s'ha celebrat al port de Torredembarra, on han assistit l'alcalde de Torredembarra, Daniel Masagué, altres autoritats i els representants
For Immediate Release November 15th, 2011 James Murphy Has Brain Tumor Relapse; Donations Welcome James Murphy, former guitarist of both Death and Testament, As well as founding member of the death metal band Disincarnate, has had a relapse of the brain tumor that sidelined him back in 2001. Murphy stated that the tumor had returned but that it was a non malignant and that it was being t